advisorsecurities master

INDVIndivior Pharmaceuticals, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
17084
Ticker
INDV
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2014-12-24
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
INDV

Detail

Enriched 2026-08-14 20:47

Market cap
$4,570,668,625.77
Shares outstanding (class)
118,013,649
Shares outstanding (weighted)
118,013,649
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
838
Location
NORTH CHESTERFIELD, VA
Description

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data